LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Clinical trials for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER NON-SMALL CELL CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat lung cancer: ivonescimab combo shows promise
Disease control Not yet recruitingThis study tests a new drug, ivonescimab, alone or with chemotherapy, in 46 people with advanced non-small cell lung cancer that has specific gene changes and has not responded to prior treatments. The goal is to see if the drug can shrink tumors or slow cancer growth. Participan…
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 09:09 UTC
-
Can volunteer navigators ease the burden of lung cancer?
Symptom relief Not yet recruitingThis study tests a program called Care and Connect, where trained volunteers help lung cancer patients find information, support, and resources. The goal is to see if the program is practical and helpful for reducing stress and improving well-being. About 50 adults with lung canc…
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC